PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2092-2099

  Li, Yongfang ^a   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; NORFLOXACIN; PEROXIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CHEMOTAXIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TOLERANCE; ESCHERICHIA COLI; FLAGELLUM; GENE EXPRESSION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH MEASUREMENT; PHENOTYPE; PHOSPHATE METABOLISM; PHOU GENE; PRIORITY JOURNAL; STARVATION; STRESS;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG TOLERANCE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HEAT-SHOCK RESPONSE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; TRANSCRIPTION FACTORS;

EID: 34250218203     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00052-07     Document Type: Article

References (29)

1. Balaban, N. Q., J. Merrin, R. Chait, L. Kowalik, and S. Leibler. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622- 1625.
2. Bauer, A. W., W. M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.
3. Bigger, J. W. 1944. Treatment of staphylococcal infections with penicillin. Lancet ii:497-500.
4. Black, D. S., B. Irwin, and H. S. Moyed. 1994. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 176:4081-4091.
5. Cole, S., R. Brosch, J. Parkhill, T. Garnier, D. H. C. Churcher, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh. J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (London) 393:537-544.
6. Correia, F. F., A. D'Onofrio, T. Rejtar, L. Li, B. L. Karger, K. Makarova, E. V. Koonin, and K. Lewis. 2006. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J. Bacteriol. 188:8360-8367.
7. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
8. Falla, T. J., and I. Chopra. 1998. Joint tolerance to p-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob. Agents Chemother. 42:3282-3284.
9. Hobby, G. L., K. Meye, and E. Chaffee. 1942. Observations on the mechanism of action of penicillin. Proc. Soc. Exp. Biol. N.Y. 50:281-285.
10. Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
11. Kleckner, N., J. Bender, and S. Gottesman. 1991. Uses of transposons with emphasis on Tn10. Methods Enzymol. 204:139-180.
12. Korch, S. B., T. A. Henderson, and T. M. Hill. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50:1199-1213.
13. Korch, S. B., and T. M. Hill. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188:3826-3836.
14. Lewis, K. 2005. Persister cells and the riddle of biofilm survival. Biochemistry 70:267-274.
15. McDermott, W. 1958. Microbial persistence. Yale J. Biol Med. 30:257-291.
16. Moyed, H. S., and K. P. Bertrand. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-775.
17. Pedersen, K., A. V. Zavialov, M. Y. Pavlov, J. Elf, K. Gerdes, and M. Ehrenberg. 2003. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 112:131-140.
18. Scherrer, R., and H. S. Moyed. 1988. Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J. Bacteriol. 170:3321-3326.
19. Steed, P. M., and B. L. Wanner. 1993. Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. J. Bacteriol. 175:6797-6809.
20. Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:107-113.
21. Vazquez-Laslop, N., H. Lee, and A. A. Neyfakh. 2006. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188:3494-3497.
22. Wade, M. M., and Y. Zhang. 2006. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. J. Antimicrob. Chemother. 58:936-941.
23. Wanner, B. 1996. Phosphorus assimilation and control of the phosphate regulon, p. 1357-1381. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, Vol. 1, 2nd ed. ASM Press, Washington, DC.
24. Wanner, B. L. 1986. Novel regulatory mutants of the phosphate regulon in Escherichia coli K-12. J. Mol. Biol. 191:39-58.
25. Wiuff, C., R. M. Zappala, R. R. Regoes, K. N. Garner, F. Baquero, and B. R. Levin. 2005. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49:1483-1494.
26. Zhang, Y. 2005. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45:529-564.
27. Zhang, Y., and D. Mitchison. 2003. The curious characteristics of pyrazinamide: a review. Int. J. Tuberc. Lung Dis. 7:6-21.
28. Zhang, Y., M. M. Wade, A. Scorpio, H. Zhang, and Z. Sun. 2003. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 52:790-795.
29. Zhang, Y., H. Zhang, and Z. Sun. 2003. Susceptibility of Mycobacterium tuberculosis to weak acids. J. Antimicrob. Chemother. 52:56-60.